EKİNCİ, F. Et Al. 2022. Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.8 , 996-1003.

EKİNCİ, F., Balcik, O. Y., Demir, B., Gursoy, P., Ozveren, A., & ERDOĞAN, A. P., (2022). Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy. Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.8, 996-1003.

EKİNCİ, FERHAT Et Al. "Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy," Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.8, 996-1003, 2022

EKİNCİ, FERHAT Et Al. "Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.8, pp.996-1003, 2022

EKİNCİ, F. Et Al. (2022) . "Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy." Journal of the College of Physicians and Surgeons Pakistan , vol.32, no.8, pp.996-1003.

@article{article, author={FERHAT EKİNCİ Et Al. }, title={Systemic Immune Inflammation Index as a Key Marker of Survival and Immune-related Adverse Events in Immune Checkpoint Inhibitor Therapy}, journal={Journal of the College of Physicians and Surgeons Pakistan}, year=2022, pages={996-1003} }